SecBot SecBot
SECBOTREPLAY Home › Report › MYGN

MYGN · Retention options to 3 execs

MYRIAD GENETICS INC · 8-K filed Nov 9, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Nov 9, 2026 at 16:01 ET

Myriad Genetics granted one-time retention stock options to three named executive officers (CFO, COO, CSO) totaling 360,944 shares, vesting on the third anniversary of the grant date. The awards are designed to retain leadership as the company executes operational efficiency and financial performance initiatives.

  • Retention Option Awards approved on November 6, 2026 for three named executive officers
  • CFO Benjamin R. Wheeler received 121,379 shares subject to option
  • COO Mark S. Verratti received 146,933 shares subject to option
  • CSO Dale Muzzey received 92,632 shares subject to option

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access